L. Wang, . Herzog, and . Rw, AAV-mediated gene transfer for treatment of hemophilia, Curr Gene Ther, vol.5, pp.349-360, 2005.

F. Mingozzi and K. A. High, Therapeutic in vivo gene transfer for genetic disease using AAV: progress and challenges, Nature reviews Genetics, vol.12, pp.341-355, 2011.

C. Zincarelli, S. Soltys, G. Rengo, . Rabinowitz, and . Je, Analysis of AAV serotypes 1-9 mediated gene expression and tropism in mice after systemic injection, Mol Ther, vol.16, pp.1073-1080, 2008.

H. Petrs-silva and R. Linden, Advances in recombinant adeno-associated viral vectors for gene delivery, Curr Gene Ther, vol.13, pp.335-345, 2013.

L. E. Mays and J. M. Wilson, The complex and evolving story of T cell activation to AAV vector-encoded transgene products, Mol Ther, vol.19, pp.16-27, 2011.

A. M. Maguire, F. Simonelli, . Pierce, . Ea, . Pugh et al., Safety and efficacy of gene transfer for Leber's congenital amaurosis, N Engl J Med, vol.358, pp.2240-2248, 2008.

C. S. Manno, . Pierce, . Gf, . Arruda, . Vr et al., , 2006.

, Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response, Nat Med, vol.12, pp.342-347

D. Gaudet, J. Methot, S. Dery, D. Brisson, C. Essiembre et al., Efficacy and long-term safety of alipogene tiparvovec (AAV1-LPLS447X) gene therapy for lipoprotein lipase deficiency: an open-label trial, Gene therapy, vol.20, pp.361-369, 2013.

F. Mingozzi, . Maus, . Mv, . Hui, . Dj et al., , 2007.

, CD8(+) T-cell responses to adeno-associated virus capsid in humans, Nat Med, vol.13, pp.419-422

S. Nayak, . Herzog, and . Rw, Progress and prospects: immune responses to viral vectors, Gene Ther, vol.17, pp.295-304, 2010.

F. Mingozzi and K. A. High, Immune Responses to AAV in Clinical Trials, Curr Gene Ther, vol.11, pp.321-330, 2011.

W. C. Manning, S. Zhou, . Bland, . Mp, J. A. Escobedo et al., Transient immunosuppression allows transgene expression following readministration of adenoassociated viral vectors, Hum Gene Ther, vol.9, pp.477-485, 1998.

P. A. Fields, . Kowalczyk, . Dw, . Arruda, . Vr et al., Role of vector in activation of T cell subsets in immune responses against the secreted transgene product factor IX, Mol Ther, vol.1, pp.225-235, 2000.

K. Yuasa, M. Yoshimura, N. Urasawa, S. Ohshima, J. M. Howell et al., Injection of a recombinant AAV serotype 2 into canine skeletal muscles evokes strong immune responses against transgene products, Gene Ther, vol.14, pp.1249-1260, 2007.

G. Gao, Q. Wang, R. Calcedo, L. Mays, P. Bell et al., Adeno-associated virus-mediated gene transfer to nonhuman primate liver can elicit destructive transgenespecific T cell responses, Hum Gene Ther, vol.20, pp.930-942, 2009.

L. Wang, E. Dobrzynski, A. Schlachterman, O. Cao, . Herzog et al., Systemic protein delivery by muscle-gene transfer is limited by a local immune response, Blood, vol.105, pp.4226-4234, 2005.

Z. Wang, . Tapscott, . Sj, J. S. Chamberlain, and R. Storb, Immunity and AAV-Mediated Gene Therapy for Muscular Dystrophies in Large Animal Models and Human Trials, Front Microbiol, vol.2, p.201, 2011.

V. Ferreira, J. Twisk, K. Kwikkers, E. Aronica, D. Brisson et al., Immune responses to intramuscular administration of alipogene tiparvovec (AAV1-LPL(S447X)) in a phase II clinical trial of lipoprotein lipase deficiency gene therapy, Hum Gene Ther, vol.25, pp.180-188, 2014.

L. Wang, O. Cao, B. Swalm, E. Dobrzynski, F. Mingozzi et al., Major role of local immune responses in antibody formation to factor IX in AAV gene transfer, Gene Ther, vol.12, pp.1453-1464, 2005.

C. S. Manno, . Chew, . Aj, S. Hutchison, . Larson et al., , 2003.

, AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B, Blood, vol.101, pp.2963-2972

V. Ferreira, H. Petry, and F. Salmon, Immune Responses to AAV-Vectors, the Glybera Example from Bench to, Bedside. Front Immunol, vol.5, p.82, 2014.

F. Mingozzi and K. A. High, Immune responses to AAV vectors: overcoming barriers to successful gene therapy, Blood, vol.122, pp.23-36, 2013.

A. C. Nathwani, . Tuddenham, . Eg, S. Rangarajan, C. Rosales et al., Adenovirus-associated virus vector-mediated gene transfer in hemophilia B, N Engl J Med, vol.365, pp.2357-2365, 2011.

A. C. Nathwani, U. M. Reiss, . Tuddenham, . Eg, C. Rosales et al., Long-term safety and efficacy of factor IX gene therapy in hemophilia B, N Engl J Med, vol.371, pp.1994-2004, 2014.

J. L. Coombes, K. R. Siddiqui, . Arancibia-cárcamo, . Cv, J. Hall et al., A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism, J Exp Med, vol.204, pp.1757-1764, 2007.

O. Schulz, E. Jaensson, . Persson, . Ek, X. Liu et al., Intestinal CD103+, but not CX3CR1+, antigen sampling cells migrate in lymph and serve classical dendritic cell functions, J Exp Med, vol.206, pp.3101-3114, 2009.

H. L. Weiner, . Cunha, . Ap, F. Quintana, and H. Wu, Oral tolerance, Immunol Rev, vol.241, pp.241-259, 2011.

H. Groux, A. Garra, M. Bigler, M. Rouleau, S. Antonenko et al., A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis, Nature, vol.389, pp.737-742, 1997.

J. Bilsborough, . George, . Tc, A. Norment, and J. L. Viney, Mucosal CD8alpha+ DC, with a plasmacytoid phenotype, induce differentiation and support function of T cells with regulatory properties, Immunology, vol.108, pp.481-492, 2003.

A. Goubier, B. Dubois, H. Gheit, G. Joubert, F. Villard-truc et al., Plasmacytoid dendritic cells mediate oral tolerance, Immunity, vol.29, pp.464-475, 2008.

Y. Chen, J. Inobe, R. Marks, P. Gonnella, V. K. Kuchroo et al., Peripheral deletion of antigen-reactive T cells in oral tolerance, Nature, vol.376, pp.177-180, 1995.

A. Friedman, . Weiner, and . Hl, Induction of anergy or active suppression following oral tolerance is determined by antigen dosage, Proc Natl Acad Sci U S A, vol.91, pp.6688-6692, 1994.

X. Zhang, L. Izikson, L. Liu, . Weiner, and . Hl, Activation of CD25(+)CD4(+) regulatory T cells by oral antigen administration, J Immunol, vol.167, pp.4245-4253, 2001.

D. K. Wherrett, B. Bundy, . Becker, . Dj, L. A. Dimeglio et al., , 2011.

, Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial, Lancet, vol.378, pp.319-327

D. Iacono, I. Tripodi, S. Calvani, M. Panetta, V. Verga et al., Specific oral tolerance induction with raw hen's egg in children with very severe egg allergy: a randomized controlled trial, Pediatr Allergy Immunol, vol.24, pp.66-74, 2013.

Y. Chung, S. Y. Chang, and C. Y. Kang, Kinetic analysis of oral tolerance: memory lymphocytes are refractory to oral tolerance, J Immunol, vol.163, pp.3692-3698, 1999.

S. Adriouch, E. Franck, L. Drouot, C. Bonneau, N. Jolinon et al., , 2011.

, Improved Immunological Tolerance Following Combination Therapy with CTLA-4/Ig and AAV-Mediated PD-L1/2, Muscle Gene Transfer. Front Microbiol, vol.2, p.199

E. Franck, C. Bonneau, L. Jean, J. P. Henry, Y. Lacoume et al., , 2012.

, Immunological tolerance to muscle autoantigens involves peripheral deletion of autoreactive CD8+ T cells, PloS one, vol.7, p.36444

E. Dobrzynski, F. Mingozzi, Y. L. Liu, E. Bendo, O. Cao et al., Induction of antigen-specific CD4+ T-cell anergy and deletion by in vivo viral gene transfer, Blood, vol.104, pp.969-977, 2004.

S. Hubert, B. Rissiek, K. Klages, J. Huehn, T. Sparwasser et al., , 2010.

, Extracellular NAD+ shapes the Foxp3+ regulatory T cell compartment through the ART2-P2X7 pathway, J Exp Med, vol.207, pp.2561-2568

R. Resta, Y. Yamashita, . Thompson, and . Lf, Ecto-enzyme and signaling functions of lymphocyte CD73, Immunol Rev, vol.161, pp.95-109, 1998.

I. A. Parish, S. Rao, . Smyth, . Gk, T. Juelich et al., The molecular signature of CD8+ T cells undergoing deletional tolerance, Blood, vol.113, pp.4575-4585, 2009.

W. C. Manning, X. Paliard, S. Zhou, P. Bland, M. Lee et al., Genetic immunization with adeno-associated virus vectors expressing herpes simplex virus type 2 glycoproteins B and D, J Virol, vol.71, pp.7960-7962, 1997.

N. Gagliani, . Magnani, . Cf, S. Huber, . Gianolini et al., , 2013.

, Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells, Nat Med, vol.19, pp.739-746

N. M. Tsuji, K. Mizumachi, and J. Kurisaki, Interleukin-10-secreting Peyer's patch cells are responsible for active suppression in low-dose oral tolerance, Immunology, vol.103, pp.458-464, 2001.

Y. Chen, J. Inobe, . Kuchroo, . Vk, . Baron et al., Oral tolerance in myelin basic protein T-cell receptor transgenic mice: suppression of autoimmune encephalomyelitis and dose-dependent induction of regulatory cells, Proc Natl Acad Sci U S A, vol.93, pp.388-391, 1996.

. Castro-junior, . Ab, . Horta, . Bc, A. C. Gomes-santos et al., Oral tolerance correlates with high levels of lymphocyte activity, Cellular immunology, vol.280, pp.171-181, 2012.

J. Sun, B. Dirden-kramer, K. Ito, P. B. Ernst, and V. Houten, Antigen-specific T cell activation and proliferation during oral tolerance induction, J Immunol, vol.162, pp.5868-5875, 1999.

S. Robert, C. Gysemans, T. Takiishi, H. Korf, I. Spagnuolo et al., Oral delivery of glutamic acid decarboxylase (GAD)-65 and IL10 by Lactococcus lactis reverses diabetes in recent-onset NOD mice, Diabetes, vol.63, pp.2876-2887, 2014.

T. Takiishi, H. Korf, V. Belle, . Tl, S. Robert et al., Reversal of autoimmune diabetes by restoration of antigen-specific tolerance using genetically modified Lactococcus lactis in mice, J Clin Invest, vol.122, pp.1717-1725, 2012.

P. Rottiers, D. Smedt, T. Steidler, and L. , Modulation of gut-associated lymphoid tissue functions with genetically modified Lactococcus lactis, Int Rev Immunol, vol.28, pp.465-486, 2009.

X. Wang, A. Sherman, G. Liao, . Leong, . Kw et al., Mechanism of oral tolerance induction to therapeutic proteins, Adv Drug Deliv Rev, vol.65, pp.759-773, 2013.

K. C. Kwon, D. Verma, ,. Singh, . Nd, R. Herzog et al., Oral delivery of human biopharmaceuticals, autoantigens and vaccine antigens bioencapsulated in plant cells, Adv Drug Deliv Rev, vol.65, pp.782-799, 2013.

D. Verma, B. Moghimi, P. A. Loduca, . Singh, . Hd et al., , 2010.

, Oral delivery of bioencapsulated coagulation factor IX prevents inhibitor formation and fatal anaphylaxis in hemophilia B mice, Proc Natl Acad Sci U S A, vol.107, pp.7101-7106